News | PACS | March 06, 2020

Ambra Health Partners With Perspectum for Around the Clock Image Access

Using Ambra Health Cloud PACS and LiverMultiScan physicians gain anywhere, anytime access to critical patient data for the improved diagnosis of liver disease

March 6, 2020 — Ambra Health, makers of the leading cloud-based, medical image management suite, today announced a partnership with Perspectum, a global leader in the development of medical image analysis technologies. Perspectum's flagship product LiverMultiScan, leverages Ambra Health's Cloud PACS to enable anytime, anywhere access to images and provide reliable, trusted cloud backup and archive to reduce business continuity risk.

LiverMultiScan is an FDA-cleared, non-invasive, quantitative imaging service, which can aid doctors in the diagnosis of liver disease with a safe, painless MRI scan. LiverMultiScan offers a high-quality method — using ground-breaking technology and rich visual images standardized across sites and manufacturers — to provide the clinician with measures related to the amount of fat, iron and fibro-inflammation in the liver. LiverMultiScan is delivered as a service after an activation protocol is enabled and does not require the purchase of any additional hardware or software.

By integrating Ambra Cloud PACS solution, physicians with LiverMultiScan enabled at their center can get access to images around the clock. Ambra Cloud PACS consolidates multiple imaging systems with one flexible, customizable, and low maintenance cloud storage platform that lets medical imaging be accessed securely anytime, anywhere.

"Early diagnosis and monitoring with quantitative non-invasive imaging are essential for patients and physicians to move away from the current dependency on liver biopsy," said Rajarshi Banerjee, M.D., Ph.D., CEO of Perspectum. "Our integration with Ambra Health ensures doctors have access to precision medicine for their liver patients, when and where they need it."

"Perspectum has created an innovative, non-invasive way for physicians to better diagnose liver conditions. Our partnership is a great example of improving patient care through imaging technology," said Andrew Duckworth, VP of Business Development at Ambra Health.

For more information: www.ambrahealth.com

Related Content

Although it is likely that existing ultrasound systems will be repurposed to treat COVID-19 patients, growth is still expected as companies plan to ramp up production. The ultrasound systems market will therefore outpace other diagnostic imaging such as computed tomography (CT) and magnetic resonance imaging (MRI). Leading data and analytics company GlobalData forecasts the market will reach $6bn by 2028, but increased usage due to COVID-19 is anticipated have a tangible effect.
News | Ultrasound Imaging | June 05, 2020
June 5, 2020 — Although it is likely that existing...
Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration, discussed The COVID-19 Pandemic — Finding Solutions, Applying Lessons Learned, on June 1

Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — The following speech was delivere
United Imaging's uMR OMEGA is designed to provide greater access to magnetic resonance imaging (MRI) with the world’s first ultra-wide 75-cm bore 3T MRI.
News | Magnetic Resonance Imaging (MRI) | May 27, 2020
May 27, 2020 — United Imaging's...
In April, the U.S. Food and Drug Administration (FDA) cleared Intelerad’s InteleConnect EV solution for diagnostic image review on a range of mobile devices.
Feature | PACS | May 27, 2020 | By Melinda Taschetta-Millane
Fast, easily accessible patient images are crucial in this day and age, as imaging and medical records take on a new
Off-site imaging companies are playing a key role in the fight against COVID-19
Feature | Coronavirus (COVID-19) | May 26, 2020 | By Sean Zahniser
After the worst of the COVID-19 pandemic has pas
There were several new developments in digital radiography (DR) technology at the 2019 Radiological Society of North America (RSNA) annual meeting. These trends included integration of artificial intelligence (AI) auto detection technologies, more durable glassless detector plates, and technologies to pull more diagnostic data out of X-ray imaging. Some vendors also have redesigned their DR systems to make them more user-friendly and ergonomic. 
Feature | Digital Radiography (DR) | May 26, 2020 | By Dave Fornell
There were several new developments in digital rad...
Lymphocytic Inflammation in a Lung from a Patient Who Died from Covid-19. The gross appearance of a lung from a patient who died from coronavirus disease 2019 (Covid-19) is shown in Panel A (the scale bar corresponds to 1 cm). The histopathological examination, shown in Panel B, revealed interstitial and perivascular predominantly lymphocytic pneumonia with multifocal endothelialitis (hematoxylin–eosin staining; the scale bar corresponds to 200 μm).

Lymphocytic Inflammation in a Lung from a Patient Who Died from Covid-19. The gross appearance of a lung from a patient who died from coronavirus disease 2019 (Covid-19) is shown in Panel A (the scale bar corresponds to 1 cm). The histopathological examination, shown in Panel B, revealed interstitial and perivascular predominantly lymphocytic pneumonia with multifocal endothelialitis (hematoxylin–eosin staining; the scale bar corresponds to 200 μm). Image courtesy of The New England Journal of Medicine

News | Coronavirus (COVID-19) | May 22, 2020
May 22, 2020 — In a new study in the New